Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis

Completed

Conditions studied: Multiple Sclerosis, Low Bone Density

In brief

The purpose of this study is to determine if certain drugs commonly used to treat multiple sclerosis have an effect on bone health.

Key facts

Study ID

NCT00490906

Run by

Nancy Hammond, MD

People needed

60

Starts

2007-06-01

Expected to finish

2012-12-01

Last updated by the study team

2014-01-22

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female, age > 18
• Able to understand and give informed consent
• Relapsing remitting multiple sclerosis (RRMS)
• Treatment with interferons or Copaxone for at least one year prior to study entry

You may not qualify if…

• Known osteoporosis
• History of hypercalcemia
• Currently pregnant
• History of primary hyperparathyroidism, hyperthyroidism, or hypothyroidism
• Unstable medical condition
• Ongoing use of bisphosphonates

Where it is running

• General Clinical Research Center — Kansas City, Kansas, United States
• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.